![](/img/cover-not-exists.png)
Long term follow-up (F/U) from SWOG 8269: concurrent cisplatin (P), etoposide (E), vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): patterns of failure and second tumors
Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)94439-3
Date:
June, 1994
File:
PDF, 174 KB
english, 1994